Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells

by Purusottam Mohapatra, Chandra Prakash Prasad, Tommy Andersson
Published 2019-02-01

Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?

by Chandra Prakash Prasad, Purusottam Mohapatra, Tommy Andersson
Published 2015-09-01

WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion

by Purusottam Mohapatra, Vikas Yadav, Maren Toftdahl, Tommy Andersson
Published 2020-02-01

Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.

by Kalpesh R Patil, Purusottam Mohapatra, Harun M Patel, Sameer N Goyal, Shreesh Ojha, Chanakya N Kundu, Chandragouda R Patil
Published 2015-01-01